Naringin Inhibits Macrophage Foam Cell Formation by Regulating Lipid Homeostasis and Metabolic Phenotype
Nutrients · 2024
DOI: 10.3390/nu16091321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Yan Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Air Force Medical Center, PLA, Beijing 100142, China. Hauptthemen laut MEDLINE: Flavanones, Foam Cells, Homeostasis, Lipid Metabolism. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Imbalances in lipid uptake and efflux and inflammation are major contributors to foam cell formation, which is considered a therapeutic target to protect against atherosclerosis. Naringin, a citrus flavonoid abundant in citrus fruits, has been reported to exert an antiatherogenic function, but its pharmacological mechanism is unclear. Naringin treatment effectively inhibits foam cell formation in THP-1 and RAW264.7 macrophages. In this study, mechanically, naringin maintained lipid homeostasis within macrophages through downregulation of the key genes for lipid uptake (MSR1 and CD36) and the upregulation of ABCA1, ABCG1 and SR-B1, which are responsible for cholesterol efflux. Meanwhile, naringin significantly decreased the cholesterol synthesis-related genes and increased the genes involved in cholesterol metabolism. Subsequently, the results showed that ox-LDL-induced macrophage inflammatory responses were inhibited by naringin by reducing the proinflammatory cytokines IL-1β, IL-6 and TNF-α, and increasing the anti- inflammatory cytokine IL-10, which was further verified by the downregulation of pro-inflammatory and chemokine-related genes. Additionally, we found that naringin reprogrammed the metabolic phenotypes of macrophages by suppressing glycolysis and promoting lipid oxidation metabolism to restore macrophage phenotypes and functions. These results suggest that naringin is a potential drug for the treatment of AS as it inhibits macrophage foam cell formation by regulating metabolic phenotypes and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Air Force Medical Center, PLA, Beijing 100142, China.
- School of Pharmacy, Anhui Medical University, Hefei 230032, China.
ORCID-Profile: Xiaohan Tang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Tang, X., Yuan, H., & Gao, R. (2024). Naringin Inhibits Macrophage Foam Cell Formation by Regulating Lipid Homeostasis and Metabolic Phenotype. Nutrients. https://doi.org/10.3390/nu16091321
Vancouver
Liu Y, Tang X, Yuan H, Gao R. Naringin Inhibits Macrophage Foam Cell Formation by Regulating Lipid Homeostasis and Metabolic Phenotype. Nutrients. 2024. doi:10.3390/nu16091321
BibTeX
@article{Liu2024,
author = {Liu, Yan and Tang, Xiaohan and Yuan, Hailong and Gao, Rong},
title = {Naringin Inhibits Macrophage Foam Cell Formation by Regulating Lipid Homeostasis and Metabolic Phenotype},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16091321}
}
EUVIMED